Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 11/20 | 0.67 |
| ▸ | PPARD | Q03181 | 9/20 | 0.67 |
| ▸ | PPARG | P37231 | 8/20 | 0.67 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.45 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.45 |
| ▸ | ITGB1 | P05556 | 3/20 | 0.45 |
| ▸ | ITGA4 | P13612 | 3/20 | 0.45 |
| ▸ | SRR | Q9GZT4 | 3/20 | 0.41 |
| ▸ | PSAT1 | Q9Y617 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5385447 | 0.88 | PPARA (0.68) | PPARAPPARDPPARGFFAR1FFAR4 | |
| SCHEMBL5377954 | 0.86 | PPARA (0.52) | PPARAPPARDPPARGFFAR1FFAR4 | |
| SCHEMBL22607958 | 0.84 | PPARA (0.91) | PPARAPPARDPPARGSRRPSAT1 | |
| SCHEMBL22607960 | 0.84 | PPARA (0.91) | PPARAPPARDPPARGSRRPSAT1 | |
| SCHEMBL5400562 | 0.80 | PPARG (1.00) | PPARAPPARDPPARGFFAR1 | |
| SCHEMBL5381961 | 0.80 | PPARG (0.84) | PPARAPPARDPPARG | |
| SCHEMBL5381218 | 0.80 | PPARG (1.00) | PPARAPPARDPPARGFFAR1 | |
| SCHEMBL5380178 | 0.80 | PPARG (0.84) | PPARAPPARDPPARGSRRPSAT1 | |
| SCHEMBL5380189 | 0.80 | PPARG (0.84) | PPARAPPARDPPARGSRRPSAT1 | |
| SCHEMBL5381121 | 0.79 | PPARG (0.94) | PPARAPPARDPPARGFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070276138-A1 | Modulators of peroxisome proliferator activated receptors | BROOKS DAWN A | 2007-11-29 | — | — | US | disclosed |
| US-7192982-B2 | Modulators of peroxisome proliferator activated receptors | LIGAND PHARMACEUTICALS, INC. (US) | 2007-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070276138-A1 | Modulators of peroxisome proliferator activated receptors | PPARG, NCOA4, PPARA | PPARA 3/4885PPARD 4/4885PPARG 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.